The optimal duration of capecitabine plus temozolomide in patients with wellâdifferentiated pancreatic NETs with or without maintenance therapy
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Neuroendocrinology"
DOI: 10.1111/jne.13112
Abstract: The optimal duration of capecitabine combined with temozolomide (CapTem) for metastatic pancreatic neuroendocrine tumours (PanNETs) remains controversial. The present study aimed to assess the activity and safety of prolonged CapTem and Cap maintenance therapy in… read more here.
Keywords: optimal duration; duration capecitabine; maintenance therapy;